樂觀
$3.37
情境價格
$85.120
-3.201 (-3.76%)收盤時
agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital.
Agilon Health is a good buy right now due to its recent positive earnings report showing a Q2 revenue of $1.49 billion, exceeding expectations, and an adjusted EPS of $2.15, far above the estimate of $0.27. The stock is currently priced at $85.12, with a significant upside potential as analysts have set a price target of $125, representing a potential upside of 47%.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Agilon Expands Partnership with The Jackson Clinic to Enhance Medicare Care

agilon Expands Partnership with Springfield Clinic to Enhance Medicare Care

Latest Rating Updates from Wall Street

Agilon Health Q2 Earnings Call Highlights

Agilon Health (AGL) Q2 2026 Earnings Call Transcript
agilon health, inc. is a healthcare company. The Company operates a Medicare-centric, capitated line of business. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing monthly payments to manage the total healthcare needs of its physician partners attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform supports the transition to a Total Care Model with technology, people, process and capital. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).
Agilon Health is a good buy right now due to its recent positive earnings report showing a Q2 revenue of $1.49 billion, exceeding expectations, and an adjusted EPS of $2.15, far above the estimate of $0.27. The stock is currently priced at $85.12, with a significant upside potential as analysts have set a price target of $125, representing a potential upside of 47%.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。